Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             37 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute apenditis in patient with acute promyelocytic leukemia Papageorgiou, Sotirios G.
2011
35 1 p. e4-e5
nvt p.
artikel
2 Alloreactive natural killer cells in hematopoietic stem cell transplantation Pegram, Hollie J.
2011
35 1 p. 14-21
8 p.
artikel
3 Antiangiogenic therapy accelerates tumor metastasis Ribatti, Domenico
2011
35 1 p. 24-26
3 p.
artikel
4 A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib Estabragh, Zahra Raisi
2011
35 1 p. 49-51
3 p.
artikel
5 Are SRC family kinases responsible for imatinib- and dasatinib-resistant chronic myeloid leukemias? Chen, Yaoyu
2011
35 1 p. 27-29
3 p.
artikel
6 Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia? Kimura, Shun-ichi
2011
35 1 p. e11-e12
nvt p.
artikel
7 Cardiotoxicity of imatinib: At the heart of the problem Tiribelli, Mario
2011
35 1 p. 36-37
2 p.
artikel
8 Combined measurement of plasma cell proliferative and apoptotic index in multiple myeloma defines patients with good and poor prognosis Minarik, Jiri
2011
35 1 p. 44-48
5 p.
artikel
9 Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study Xiao, Zhijian
2011
35 1 p. 61-65
5 p.
artikel
10 3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase Raynal, Noël J.-M.
2011
35 1 p. 110-118
9 p.
artikel
11 Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF Smith, B. Douglas
2011
35 1 p. 87-94
8 p.
artikel
12 Editorial Board 2011
35 1 p. CO2-
1 p.
artikel
13 Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains Chang, Hong
2011
35 1 p. 95-98
4 p.
artikel
14 Introduction to an occasional series Bowen, David T.
2011
35 1 p. 1-2
2 p.
artikel
15 Is imatinib-related cardiotoxicity still an open issue? Breccia, Massimo
2011
35 1 p. 34-35
2 p.
artikel
16 KIAA1524: A novel MLL translocation partner in acute myeloid leukemia Coenen, Eva A.
2011
35 1 p. 133-135
3 p.
artikel
17 Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients Hayette, Sandrine
2011
35 1 p. 38-43
6 p.
artikel
18 Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome Tabouret, Emeline
2011
35 1 p. 136-
1 p.
artikel
19 MPN-associated myelofibrosis (MPN-MF) Mesa, R.A.
2011
35 1 p. 12-13
2 p.
artikel
20 Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias Park, Sang Wook
2011
35 1 p. e6-e7
nvt p.
artikel
21 NF-κB localization in multiple myeloma plasma cells and mesenchymal cells Conticello, Concetta
2011
35 1 p. 52-60
9 p.
artikel
22 No mutation in the FOXP3 gene in acute leukemias Kim, Min Sung
2011
35 1 p. e10-
1 p.
artikel
23 On the assessment of dasatinib-induced autophagy in CLL Krause, Günter
2011
35 1 p. 137-138
2 p.
artikel
24 Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol Haïat, Stéphanie
2011
35 1 p. 66-72
7 p.
artikel
25 p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes Amrein, Lilian
2011
35 1 p. 99-102
4 p.
artikel
26 Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone Nicolini, Franck E.
2011
35 1 p. 80-86
7 p.
artikel
27 Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib Valent, Jason N.
2011
35 1 p. e1-e3
nvt p.
artikel
28 Renewed interest in myeloma tumor growth, or just one more method to assess proliferation? Ely, Scott
2011
35 1 p. 30-31
2 p.
artikel
29 Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25 Zhang, Li
2011
35 1 p. 103-109
7 p.
artikel
30 Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription Brown, N.L.
2011
35 1 p. 126-132
7 p.
artikel
31 Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia? Grimwade, David
2011
35 1 p. 3-7
5 p.
artikel
32 The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cells Schwarz, Kerstin
2011
35 1 p. 119-125
7 p.
artikel
33 The role of p53 and autophagy in Dasatinib resistance of CLL lymphocytes Pitini, Vincenzo V.
2011
35 1 p. 32-33
2 p.
artikel
34 Transient marked increase in lymphocytosis during acute illness in chronic lymphocytic leukemia Sandhu, Indermohan
2011
35 1 p. e8-e9
nvt p.
artikel
35 Treatment of anemia with erythroid stimulating agents in myelodysplastic syndromes Della Porta, Matteo G.
2011
35 1 p. 22-23
2 p.
artikel
36 Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation Shi, Cheng-jun
2011
35 1 p. 73-79
7 p.
artikel
37 What are RBC-transfusion-dependence and -independence? Gale, R.P.
2011
35 1 p. 8-11
4 p.
artikel
                             37 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland